Purple toe syndrome From Dr Munir E Nassar 245 South Main Street Albion, New York 144JJ, USA Dear Sir, The rebuttal by Mr Akle and Dr Joiner (August Journal, p 632) of my suggestion (July, p 557) ofwarfarin vasculitis with clinical manifestation of Raynaud's phenomenon, and a remote possibility of embolic disease, is interesting.
The weight of evidence in the literature that the purple toe syndrome exists is meagre.
Pathologically, dilatation of small peripheral dermal vessels without endothelial thickening, and inflammatory cell infiltration of vessel walls, have been documented in genuine cases of vasculitis or necrotizing angiitis and the clinical picture of Raynaud's phenomenon (Beeson et al. 1979 A copy of this letter was sent to Mr Akle and Dr Joiner, who have replied as follows: Sir, We feel that all Dr Nassar's comments were adequately answered in our previous letter (August, p 632) and do not consider that any of his criticisms apply to our clinical description of the case (March, p 219 This analytical review of the literature has been published to provide a firm basis and background to this initiative. Confined to work in the English language between 1959 and 1975, the review includes literature from the United Kingdom. It consists of 350 short abstracts, preceded by a discussion which assesses the ground which they
